Pacific Biosciences of California Inc. (PacBio) has announced a new collaboration with iHope, a global rare disease genomics program of Genetic Alliance. As the first long-read genomic sequencing partner for iHope, PacBio will integrate its HiFi long-read whole-genome sequencing technology into iHope's international network starting in early 2026. This partnership aims to enhance the network's ability to diagnose rare diseases by providing more comprehensive genomic analysis, especially for challenging regions of the genome and complex genetic variations. The collaboration is also designed to support future research into precision therapeutic approaches for rare disease patients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief on February 12, 2026, and is solely responsible for the information contained therein.